What is the drug of choice for treating dysentery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drug of Choice for Dysentery

Azithromycin is the drug of choice for dysentery, with a recommended dose of 1000 mg as a single dose or 500 mg daily for 3 days. 1, 2

First-Line Treatment Recommendation

Azithromycin should be the preferred agent for all cases of dysentery (bloody diarrhea with mucus or pus), regardless of geographic region. 2, 3 This recommendation is based on:

  • Superior efficacy against the most common dysentery pathogens (Shigella species and Campylobacter), with studies showing 100% clinical and bacteriological cure rates 2
  • Excellent safety profile compared to fluoroquinolones, which carry black box warnings for tendon rupture, C. difficile infection, and QT prolongation 1, 2
  • Global fluoroquinolone resistance patterns that now exceed 85% for Campylobacter in Southeast Asia and are increasing worldwide 3

Dosing Regimens

For adults with dysentery: 1, 2

  • Single 1000 mg dose (preferred for compliance), OR
  • 500 mg daily for 3 days

For children: 1

  • 30 mg/kg/day for 5 days (based on older guidelines, though newer evidence supports adult-equivalent dosing)

Alternative Agents When Azithromycin Is Not Available

Ciprofloxacin (Second-Line)

Ciprofloxacin remains an option in regions with documented low fluoroquinolone resistance, but should not be first-line due to increasing resistance and safety concerns. 1

  • Adults: 500 mg twice daily for 3 days, or 750 mg single dose 1, 4
  • Children: 15 mg/kg/day (though associated with arthropathy risk) 1
  • Critical limitation: Resistance rates to ciprofloxacin now reach 5.0% in Asia-Africa and are progressively increasing, with even higher rates in children than adults 1

Cefixime or Ceftriaxone (Third-Line)

Oral cefixime or parenteral ceftriaxone are appropriate alternatives when azithromycin and fluoroquinolones have failed or resistance is documented. 1

  • Resistance rates to ceftriaxone remain relatively low (2.5% in Asia-Africa, 0.4% in Europe-America) 1
  • Particularly useful for severe cases requiring hospitalization 1

Historical Context: Older Regimens No Longer Recommended

The 1992 guidelines recommended ampicillin or TMP-SMX as first-line agents 1, but these are now obsolete due to widespread multidrug resistance. 1 Resistance rates to ampicillin and cotrimoxazole are now extremely high globally, making them ineffective for empiric therapy. 1, 5

Critical Diagnostic Considerations

Before treating for dysentery, attempt to distinguish bacterial from amebic causes when possible: 1, 6

  • Microscopic examination of fresh stool should be performed to identify Entamoeba histolytica trophozoites 1, 6
  • Amebic dysentery is frequently misdiagnosed and tends to be overdiagnosed 6
  • If microscopy is unavailable or negative for amoeba, treat empirically for bacterial dysentery (Shigella) first 1, 6
  • Only consider amebic treatment if: microscopy shows definite trophozoites OR two different antibiotics for shigellosis have failed 1, 6

Treatment for Confirmed Amebic Dysentery

Metronidazole 750 mg orally three times daily for 5-10 days (adults) or 30 mg/kg/day for 5-10 days (children) 1, 6

  • Must be followed by a luminal amebicide (diloxanide furoate 500 mg three times daily for 10 days or paromomycin 30 mg/kg/day in 3 divided doses for 10 days) to prevent relapse 6

Common Pitfalls to Avoid

  1. Do not use rifaximin for dysentery - it has documented treatment failures in up to 50% of cases with invasive pathogens and is only appropriate for non-invasive watery diarrhea 1, 3

  2. Do not delay antibiotic change if no clinical response within 48 hours - switch to an alternative agent rather than continuing ineffective therapy 1

  3. Do not use antimotility agents (loperamide) in dysentery - these are contraindicated in bloody diarrhea as they may worsen invasive disease 7

  4. Do not assume fluoroquinolones are still universally effective - regional resistance patterns must guide therapy, and azithromycin is now preferred globally 1, 2

  5. Do not treat presumed amebiasis without microscopic confirmation or documented antibiotic failure - this leads to inappropriate treatment and delays proper bacterial dysentery management 1, 6

Adjunctive Therapy

Oral rehydration solution should be given concurrently to prevent or correct dehydration 1, 7

Feeding should continue during and after illness to maintain nutritional status 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

IV Azithromycin for Bacterial Gastroenteritis Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Traveler's Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antimicrobial therapy for shigellosis.

Reviews of infectious diseases, 1991

Guideline

Treatment of Amoebic Dysentery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An evaluation of current shigellosis treatment.

Expert opinion on pharmacotherapy, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.